ARTICLE | Clinical News
ISIS-PTP1BRx: Phase II data
February 9, 2015 8:00 AM UTC
Top-line data from a double-blind, international Phase II trial in 92 obese patients with uncontrolled Type II diabetes showed that once-weekly 200 mg ISIS-PTP1BRx plus metformin and/or a sulfonyurea ...